Market Apimeds Pharmaceuticals starts trading at $4 per share in line with IPO pricing By forbesmagzine - May 9, 2025 0 1 FacebookTwitterPinterestWhatsApp [ad_1] Apimeds Pharmaceuticals starts trading at $4 per share in line with IPO pricing [ad_2] Source link
